Cargando…
Locoregional control and survival after lymph node SBRT in oligometastatic disease
Stereotactic body radiotherapy (SBRT) has emerged as an effective option in oligo-metastatic cancer patients affected by lymph node metastases, but its use might be questioned due to risk of regional and distant dissemination through the lymph node chain. The primary aim of our study was to assess t...
Autores principales: | Loi, Mauro, Frelinghuysen, Michael, Klass, Natalie Desiree, Oomen-De Hoop, Esther, Granton, Patrick Vincent, Aerts, Joachim, Verhoef, Cornelis, Nuyttens, Joost |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6209001/ https://www.ncbi.nlm.nih.gov/pubmed/29995254 http://dx.doi.org/10.1007/s10585-018-9922-x |
Ejemplares similares
-
Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases
por: Yeung, Rosanna, et al.
Publicado: (2017) -
SBRT treatment of abdominal and pelvic oligometastatic lymph nodes using ring‐mounted Halcyon Linac
por: Pokhrel, Damodar, et al.
Publicado: (2021) -
Clinical Outcomes of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Patients with Lymph Node Metastases from Gynecological Cancers
por: Facondo, Giuseppe, et al.
Publicado: (2023) -
Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
por: de Jong, Mees Hendrik Siert, et al.
Publicado: (2022) -
Impact of Using Unedited CT-Based DIR-Propagated Autocontours on Online ART for Pancreatic SBRT
por: Magallon-Baro, Alba, et al.
Publicado: (2022)